Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic recurrent polychondritis]

K Benning1, U Müller-Ladner, G Rauh

  • 1Klinik und Poliklinik für Innere Medizin I, Bereich Rheumatologie und Klinische Immunologie, Universität Regensburg.

Zeitschrift Fur Rheumatologie
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workplace bullying and suicidal ideation and behaviour: a systematic review and meta-analysis.

Public health·2023
Same author

A feline model of spontaneously occurring autoimmune limbic encephalitis.

Veterinary journal (London, England : 1997)·2023
Same author

Factors influencing nodal yield in neck dissections for head and neck malignancies.

The Journal of laryngology and otology·2023
Same author

Dysphagia incidence in intensive care unit patients with coronavirus disease 2019: retrospective analysis following systematic dysphagia screening.

The Journal of laryngology and otology·2022
Same author

Safety of elective paediatric surgery during the coronavirus disease 2019 pandemic.

International journal of pediatric otorhinolaryngology·2021
Same author

Outcomes of preoperative real-time polymerase chain reaction testing for SARS CoV-2 in elective otolaryngology surgical patients during the pandemic: a prospective cohort study.

The British journal of surgery·2021
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Relapsing polychondritis (RP) is a rare autoimmune disease causing inflammation in cartilage. Early diagnosis and treatment are crucial for managing this chronic condition and its potential complications.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Context:

  • Relapsing polychondritis (RP) is a rare, chronic, and recurrent autoimmune disorder of unknown cause.
  • It primarily affects cartilaginous structures, including ears, nose, respiratory tract, and joints.

Purpose:

  • To summarize the key features, pathogenesis, and management of relapsing polychondritis.
  • To highlight the role of immunologic mechanisms and associated conditions in RP.

Summary:

  • RP involves inflammation of cartilage, with potential links to HLA-DR4 and autoantibodies like anti-type-II collagen.
  • Associated conditions include other rheumatic/autoimmune diseases, vasculitis affecting various organs (eyes, cardiovascular, CNS), and audiovestibular issues.
  • Disease course is variable; severity depends on associated diseases and vasculitis. Treatment involves NSAIDs, corticosteroids, and cytotoxic agents.

Related Experiment Videos

Impact:

  • Understanding RP's immunologic basis aids in developing targeted therapies.
  • Recognizing associated conditions and vasculitis is vital for comprehensive patient management and improved outcomes.
  • This information supports clinicians in diagnosing and treating this complex autoimmune disease.